The News
Persistent Systems has launched an AI-powered generative molecules and virtual screening solution utilizing the NVIDIA BioNeMo framework, aimed at enhancing early-stage drug discovery.
Why It Matters
This development signifies a strategic advancement in AI applications within the pharmaceutical sector, potentially accelerating drug discovery processes and reducing costs. The collaboration with NVIDIA highlights the increasing integration of advanced AI technologies in healthcare.
Key Evidence
The information is sourced from a press release by Persistent Systems, indicating a verified announcement.
Original Article
finanznachrichten
DE source 路 Published yesterday
https://www.finanznachrichten.de/nachrichten-2026-03/67961268-persistent-systems-persistent-launches-ai-powered-generative-molecules-and-virtual-screening-solution-powered-by-nvidia-008.htm